Rheon Medical Receives FDA Breakthrough Device Designation for the eyeWatch Technology to Treat Refractory Glaucoma.
May 20, 2021
Emmanuel de Watteville, General Partner @ Blue Ocean Ventures speaks about who's financing our life sciences' start-ups
April 22, 2021
CyanoGuard raises USD 0.5 million to advance sustainability and efficiency in gold mining.
April 19, 2021
MIKAJAKI Announces CE Marking for EyeLib™, the World’s First Automated Ophthalmic Diagnostic Platform.
November 3, 2020
Luciole Medical AG and Hôpital Fondation Adolphe de Rothschild enter research collaboration in brain oxygenation monitoring.
July 30, 2020
BlueOcean Ventures invests in MIKAJAKI, inventor of the world’s first ophthalmic diagnostic robotic platform.
April 24, 2020
CyanoGuard raises over CHF 3m and closes seed round led by Wingman Ventures.
April 24, 2020
Rheon Medical SA announced that it has received the CE mark for its first-in-class eyeWatch system, which is used for the surgical treatment of glaucoma.
January 14, 2020
Last week, the official announcement of a partnership agreement between Abionic and Genentech was released.
September 21, 2019
In the TOP 100 Swiss Startup Awards, Abionic was ranked among the best Swiss ‘Scale-ups’ whereas AVA finished No 3 and Volumina finished No 15.
September 6, 2019
BlueOcean Ventures ll becomes the first tokenized medtech VC fund with the launch of a dedicated STO platform, SwissVCToken, to allow token holders to gain profit from startup investments
October 19, 2018
Luciole Medical Raises CHF 5.3 Million in Series A Financing for Novel Brain Monitoring Platform
September 27, 2018
Ava – Maker of First Fertility Tracking Sensor Bracelet - Closes $30M Series B Funding Round and Announces 10,000th “ Ava” Pregnancy
August 28, 2018
Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPEâ Diagnostic Testing Platform
October 24, 2017
Ava – Makers of First Fertility Tracking Sensor Bracelet - Announces Close of $10M Series A Round
November 21, 2016